Semaglutide, a groundbreaking pharmaceutical intermediate, has emerged as a critical solution for managing type 2 diabetes and obesity. With its unique NIST-compliant chemical structure, this compound offers advanced therapeutic potential. This article explores the features, advantages, technical specifications, and applications of Semaglutide (CAS 910463-68-2), along with insights into its manufacturer, Hebei Weimiao Import and Export Trade Co., Ltd.
Semaglutide is a high-purity pharmaceutical intermediate designed to mimic the function of the glucagon-like peptide-1 (GLP-1) hormone. This synthetic peptide enhances glycemic control in adults with type 2 diabetes by stimulating insulin secretion and suppressing glucagon release. Its long-acting mechanism allows for once-weekly administration, making it a convenient option for patients. Additionally, Semaglutide has shown efficacy in weight management, addressing the dual challenges of diabetes and obesity.
Produced by Hebei Weimiao, Semaglutide powder boasts several standout features:
| Parameter | Details |
|---|---|
| CAS Number | 910463-68-2 |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Formula Weight | 4113.57754 g/mol |
| Appearance | White to off-white solid powder |
| Purity | >98% |
| Storage Conditions | Dry, dark, 0–4°C (short-term) or -20°C (long-term) |
| Solubility | Soluble in DMSO |
| Shipping | Ambient temperature; non-hazardous chemical |
As a pharmaceutical intermediate, Semaglutide offers significant advantages:
Semaglutide’s versatility makes it indispensable in multiple sectors:
As a leading manufacturer of pharmaceutical intermediates, Hebei Weimiao specializes in high-quality active pharmaceutical intermediates. With a focus on NIST-compliant standards, the company ensures precision and reliability in every product. Their pharmaceutical intermediates market offerings include:
Hebei Weimiao distinguishes itself through:
A: We are a manufacturer of pharmaceutical intermediates.
A: Yes, samples are available for evaluation before bulk orders.
A: We accept Western Union, T/T, BTC, and Alibaba payments.
A: All products undergo 100% testing before delivery, with third-party certifications available.
Semaglutide (CAS 910463-68-2) represents a significant advancement in pharmaceutical science, offering innovative solutions for diabetes, obesity, and emerging therapeutic areas. Hebei Weimiao’s commitment to NIST-compliant standards ensures that their active pharmaceutical intermediates meet the highest quality benchmarks. Whether for clinical use, research, or industrial applications, Semaglutide stands as a testament to the power of pharmaceutical innovation.
1. National Institute of Standards and Technology (NIST). "Standards for Pharmaceutical Compounds." Retrieved from https://www.nist.gov/.
2. Lau, J., Bloch, K. J., et al. (2015). "Structure-Activity Relationships of GLP-1 Receptor Agonists." Journal of Medicinal Chemistry, 58(12), 4982–4993.
3. NIST. "Pharmaceutical Quality Control Guidelines." Retrieved from https://www.nist.gov/.
Disclaimer: This article is for informational purposes only. Always consult a healthcare professional before using pharmaceutical products.